Long noncoding RNAs in head and neck squamous cell carcinoma: biological functions and mechanisms - PubMed (original) (raw)
Review
. 2020 Oct;47(10):8075-8090.
doi: 10.1007/s11033-020-05777-w. Epub 2020 Sep 10.
Affiliations
- PMID: 32914266
- DOI: 10.1007/s11033-020-05777-w
Review
Long noncoding RNAs in head and neck squamous cell carcinoma: biological functions and mechanisms
Jiayu Zhao et al. Mol Biol Rep. 2020 Oct.
Abstract
Head and neck squamous cell carcinoma (HNSCC) is the primary malignant tumor of the oral cavity, larynx, nasopharynx, esophagus and tongue. Although several novel therapeutic methods for HNSCC have been developed, the final therapeutic effect on the patient is still not satisfactory. Thus, it is imperative that scientists identify novel distinguishable markers with specific molecular characteristics that can be used in therapeutic and prognostic evaluation. Previous reports have shown that long noncoding RNAs (lncRNAs) are important regulators of gene expression in many cancers, including head and neck squamous cell carcinomas. Translational studies of lncRNAs in HNSCC are urgently required before their application as a treatment can be realized. We aimed to address the most relevant findings on lncRNAs as biomarkers or treatment targets in head and neck squamous cell carcinoma and to summarize their discovered pathways and mechanisms of action to reveal the possible future applications of these novel biomarkers in clinical translational research.
Keywords: Biomarkers; Head and neck squamous cell carcinoma; Laryngeal squamous cell carcinoma; Long noncoding RNA; Nasopharyngeal carcinoma; Oral squamous cell carcinoma.
Similar articles
- Knockdown of LINC01116 inhibits cell migration and invasion in head and neck squamous cell carcinoma through epithelial-mesenchymal transition pathway.
Wu J, Chen Z, Zhang L, Cao J, Li X, Gong Z, Bo H, Zhang S, He D. Wu J, et al. J Cell Biochem. 2020 Jan;121(1):867-875. doi: 10.1002/jcb.29331. Epub 2019 Aug 26. J Cell Biochem. 2020. PMID: 31452270 - The cox-filter method identifies respective subtype-specific lncRNA prognostic signatures for two human cancers.
Tian S, Wang C, Zhang J, Yu D. Tian S, et al. BMC Med Genomics. 2020 Feb 5;13(1):18. doi: 10.1186/s12920-020-0691-4. BMC Med Genomics. 2020. PMID: 32024523 Free PMC article. - Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG, Li H, Xiao Y, Yang QC, Yang LL, Chen L, Bu LL, Zhang WF, Zhang JL, Sun ZJ. Xiong HG, et al. J Exp Clin Cancer Res. 2019 Jun 25;38(1):278. doi: 10.1186/s13046-019-1254-4. J Exp Clin Cancer Res. 2019. PMID: 31238980 Free PMC article. - Long non-coding RNAs in head and neck squamous cell carcinoma: Diagnostic biomarkers, targeted therapies, and prognostic roles.
Meng X, Wang ZF, Lou QY, Rankine AN, Zheng WX, Zhang ZH, Zhang L, Gu H. Meng X, et al. Eur J Pharmacol. 2021 Jul 5;902:174114. doi: 10.1016/j.ejphar.2021.174114. Epub 2021 Apr 23. Eur J Pharmacol. 2021. PMID: 33901464 Review. - Long noncoding RNAs in head and neck cancer.
Li X, Cao Y, Gong X, Li H. Li X, et al. Oncotarget. 2017 Feb 7;8(6):10726-10740. doi: 10.18632/oncotarget.12960. Oncotarget. 2017. PMID: 27802187 Free PMC article. Review.
Cited by
- Suppression of Long Noncoding RNA SNHG1 Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma via Increasing PARP6 Expression.
Chen Q, He X, Li B, Chen J, Tang X. Chen Q, et al. Evid Based Complement Alternat Med. 2022 Jul 5;2022:1562219. doi: 10.1155/2022/1562219. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35836822 Free PMC article. - The Role and Mechanism of MALAT1 Long Non-Coding RNA in the Diagnosis and Treatment of Head and Neck Squamous Cell Carcinoma.
Ye D, Deng Y, Shen Z. Ye D, et al. Onco Targets Ther. 2021 Jul 8;14:4127-4136. doi: 10.2147/OTT.S317234. eCollection 2021. Onco Targets Ther. 2021. PMID: 34267526 Free PMC article. Review. - Long Non-Coding RNA UBA6-AS1 Promotes the Malignant Properties of Glioblastoma by Competitively Binding to microRNA-760 and Enhancing Homeobox A2 Expression.
Cheng F, Liu J, Zhang Y, You Q, Chen B, Cheng J, Deng C. Cheng F, et al. Cancer Manag Res. 2021 Jan 14;13:379-392. doi: 10.2147/CMAR.S287676. eCollection 2021. Cancer Manag Res. 2021. PMID: 33469379 Free PMC article. Retracted. - Local and Systemic Delivery of the BimS Gene Nano-Complex for Efficient Oral Squamous Cell Carcinoma Therapy.
Ma P, Li J, Gao Y, Wu J, Men K, Li C, Men Y, Duan X. Ma P, et al. Int J Nanomedicine. 2022 Jul 4;17:2925-2941. doi: 10.2147/IJN.S357702. eCollection 2022. Int J Nanomedicine. 2022. PMID: 35814613 Free PMC article. - Long noncoding RNA SLC9A3‑AS1 increases E2F6 expression by sponging microRNA‑486‑5p and thus facilitates the oncogenesis of nasopharyngeal carcinoma.
Li J, Li D, Zhang X, Li C, Zhu F. Li J, et al. Oncol Rep. 2021 Aug;46(2):165. doi: 10.3892/or.2021.8116. Epub 2021 Jun 24. Oncol Rep. 2021. PMID: 34165171 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical